Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data

Hot M&A Catch-Up: Johnson & Johnson, Yamana

Stock Markets Nov 07, 2022 08:44
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
PAAS
-7.15%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GFI
-4.42%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MRO
-0.61%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
JNJ
-0.56%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AUY
-4.83%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Gold
-2.75%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Sarina Isaacs, Reuters

Investing.com - Here are the hottest pieces of M&A news from the past week, as covered first on InvestingPro+.

Pan American Silver (NASDAQ:PAAS) Corp. and Agnico Eagle (NYSE:AEM) Limited announced a definitive binding $4.8 billion offer to acquire Yamana Gold (NYSE:AUY) Inc. to rival Gold Fields' (NYSE:GFI) planned acquisition of the Canada-listed miner. The deal would see pan American and Agnico Eagle split Yamana's mines between them. Gold Fields' all-stock author was worth $6.7 billion when first inked in May, but a slump in its shares has brought the offer's value to just north of $4 billion. Yamana rose 11.6% for the week; Pan American lost 6.5%; Agnico Eagle dropped 1.3%; and Gold Fields climbed 8%.

Johnson & Johnson (NYSE:JNJ) agreed to acquire Abiomed (NASDAQ:ABMD) for an upfront payment of $380 per share, or $16.6 billion. Abiomed shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $35 per share in cash if certain commercial and clinical milestones are achieved. Abiomed leapt 48.4% for the week; Johnson & Johnson slipped 1.4%.

Poseidon Acquisition agreed to buy marine and energy asset owner Atlas (NYSE:ATCO) Corp. for $15.50 per share, or $10.98 billion, in an all-cash transaction. Poseidon is an investment vehicle backed by Atlas's current chairman, David Sokol, among others. Atlas was up 3.3% for the week.

Voya Financial (NYSE:VOYA) agreed to buy Benefitfocus (NASDAQ:BNFT) for 10.50 per share, or $570 million, in an all-cash transaction. Benefitfocus soared 47.4% for the week; Voya was off 2.1%.

Marathon Oil (NYSE:MRO) said it would acquire Ensign Natural Resources' Eagle Ford assets for $3 billion in cash. Marathon Oil shares rose 5.2% for the week.

Hot M&A Catch-Up: Johnson & Johnson, Yamana
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email